| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2026―Jan―23 |
Immune and infection-associated forms of neonatal thrombosis. The role of antiphospholipid syndrome (APS), catastrophic APS, vaccine-induced immune thrombotic thrombocytopenia, and COVID-19 |
V.O. Bitsadze, J.Kh. Khizroeva, M.V. Tretyakova, N.A. Makatsariya, S.V. Cherkasova, N.R. Gashimova, et al. (+12) K.N. Grigoreva, I.S. Kalashnikova, A.V. Vorobev, A.R. Khisamieva, M.N. Kozmova, K.I. Myachina, A.L. Karpova, A.V. Mostovoi, Zh.-C. Gris, I. Elalamy, G. Gerotziafas, A.D. Makatsariya |
| 2 |
[GO] |
2025―Jan―28 |
COVID-19, endothelial dysfunction and immunothrombosis |
N.R. Gashimova, K.N. Grigoreva, V.O. Bitsadze, J.Kh. Khizroeva, M.V. Tretyakova, N.A. Makatsariya, et al. (+8) N.D. Degtyareva, E.S. Kudryavtseva, A.Yu. Shatilina, C. Ay, J.-Ch. Gris, I. Elalamy, G. Gerotziafas, A.D. Makatsariya |
| 3 |
[GO] |
2025―Jan―27 |
Prognostic criteria for preterm birth in pregnant women infected with COVID-19 in the third trimester: a case-control study |
N.S. Bozhbanbayeva, K.K. Urstemova, A.S. Tarabayeva, E.Zh. Bitanova, A.A. Abilbayeva, I.E. Suleimenova |
| 4 |
[GO] |
2024―Apr―01 |
Pathways and mechanisms of effects of maternal COVID-19 infection on fetal nervous system development |
D.Yu. Kapralova, K.A. Yangelbiev, O.A. Shlenkina, L.G. Esayan, N.N. Gusak, D.R. Kandaurov, et al. (+6) G.A. Aleshichev, E.A. Kvasnina, A.V. Pertseva, D.A. Neverova, G.V. Muratshina, D.D. Gilyazov |
| 5 |
[GO] |
2024―Apr―01 |
Incidence of benign breast dysplasia: before and during the pandemic |
O.Yu. Sevostyanova, N.V. Bashmakova, T.V. Chumarnaya, T.A. Oboskalova, N.E. Sevostyanova |
| 6 |
[GO] |
2024―Feb―12 |
Risk factors for intrauterine fetal demise in pregnant women with complicated obstetric history and COVID-19 during pregnancy |
K.K. Urstemova, N.S. Bozhbanbaeva, R.Z. Boranbaeva, A.S. Tarabayeva, E.Zh. Bitanova, A.A. Abilbayeva, I.E. Suleymenova |
| 7 |
[GO] |
2023―Aug―17 |
COVID-19, thromboinflammation and hemostatic dysregulation in pregnant women |
V.O. Bitsadze, N.R. Gashimova, K.N. Grigoryeva, D.Kh. Khizroeva, M.V. Tretyakova, N.D. Degtyareva, et al. (+7) M.V. Kvaratskheliia, F.E. Yakubova, I.K. Nakaidze, J-Ch. Gris, I. Elalami, E.V. Slukhanchuk, A.D. A.D.Makatsariya |
| 8 |
[GO] |
2023―Aug―15 |
Heparin-induced thrombocytopenia against COVID-19 in a patient with cancer |
A.V. Vorobev, K.R. Khalieva, E.V. Maslenkova, A.G. Solopova, V.O. Bitsadze, D.Kh. Khizroeva, et al. (+4) N.D. Degtyareva, F.E. Yakubova, M.E. Zelepukhina, A.D. Makatsariya |
| 9 |
[GO] |
2023―Mrz―22 |
Characteristics of cardiotocography in pregnant women with mild COVID-19 in the third trimester |
R.S. Zamaleeva, N.A. Cherepanova, A.V. Frizina, E.Yu. Iupatov |
| 10 |
[GO] |
2023―Jan―16 |
Pharmacotherapy for pregnant women with arterial hypertension considering pathogenetic factors during the SARS-CoV-2 pandemic |
N.A. Konyshko, T.E. Morozova, A.S. Konyshko |
| 11 |
[GO] |
2022―Dez―30 |
Assessment of the effectiveness of COVID-19 preventive measures in pregnant women |
T.E. Belokrinitskaya, N.I. Frolova, K.A. Kolmakova, E.A. Shametova, I.Yu. Veselkova, Sh.R. Osmonova |
| 12 |
[GO] |
2022―Jul―01 |
Thrombocytopenia mimicking HELLP syndrome in a pregnant woman with COVID-19 |
L.I. Dvoretsky, A.I. Davydov, N.V. Dyatlov, Zh.R. Doshchanova, I.A. Klindukhov |
| 13 |
[GO] |
2022―Apr―11 |
Characteristics of COVID-19 in peri- and postmenopausal women. Role of hormone replacement therapy |
L.A. Marchenkova, E.V. Makarova |
| 14 |
[GO] |
2022―Apr―08 |
Clinical characteristics of novel coronavirus infection and efficacy of intranasal interferon alpha in pregnant women with COVID-19 and in newborns with perinatal exposure |
A.V. Romanovskaya, T.N. Malyugina, E.V. Mikhaylova, N.V. Malinina, P.A. Zheleznikov, T.K. Chudakova, et al. (+4) A.Yu. Serdyukov, E.E. Raskina, O.S. Burova, N.E. Denisyuk |
| 15 |
[GO] |
2022―Jan―17 |
COVID-19: pregnancy and childbirth outcomes after treatment with recombinant interferon α-2b |
E.N. Kravchenko, L.V. Kuklina, E.M. Ovchinnikova, V.Yu. Chebakova, E.N. Vyzhlova, I.I. Baranov |
| 16 |
[GO] |
2021―Dez―13 |
Immunotherapy of cervical intraepithelial neoplasia associated with human papillomavirus in the COVID-19 pandemic. Clinicians’ view |
A.I. Davydov, R.A. Chilova, M.N. Shakhlamova, V.A. Lebedev |
| 17 |
[GO] |
2021―Jul―08 |
Prevention of ARVI in newborns and their mothers under pandemic conditions of new coronavirus infection |
I.I. Bocharova, N.V. Zarochentseva, A.N. Aksenov, V.V. Malinovskaya, E.N. Vyzhlova, A.Yu. Suvorov, T.A. Semenenko |
|
